Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 816 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| North America | 3,498 |
| Europe | 1,639 |
| Asia-Pacific | 816 |
| Latin America | 101 |
| Middle East | 48 |
| Africa | 42 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| China | 365 |
| Japan | 155 |
| South Korea | 85 |
| Australia | 79 |
| Taiwan | 38 |
| India | 25 |
| Thailand | 17 |
| Singapore | 12 |
Trial sites
816 sites. Sites with a public page link to it on Pharma Observatory.
-
Zhongda Hospital Southeast University 198 trials
-
Jilin Cancer Hospital 197 trials
-
Princess Margaret Hospital for Children 195 trials
-
Henan Cancer Hospital 193 trials
-
Kyushu University Hospital 192 trials
-
Research Site 191 trials
-
Xuanwu Hospital, Capital Medical University 191 trials
-
National Cancer Center Hospital 190 trials
-
Hokkaido University Hospital 189 trials
-
Research Site 189 trials
-
Chinese PLA General Hospital 187 trials
-
Chung-Ang University Hospital 187 trials
-
Shanghai Mental Health Center 187 trials
-
Research Site 183 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.